10 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 8 Phase 1, 8 Phase 2, 3 Phase 3, 1 Not applicable.
Follow chiauranib: new trials by email Literature Review of chiauranib trials Research Report on chiauranib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Chiauranib, Toripalimab Injection, Albumin-paclitaxel Injection - Metastatic Pancreatic Ductal Adenocarcinoma | Phase 3 | Not yet recruiting | Chipscreen Biosciences, Ltd. | 558 | 2026-03-31 | 2026-03-03 |
| Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma Chiauranib, Albumin-paclitaxel Injection, Gemcitabine Injection - Pancreatic Ductal Adenocarcinoma | Phase 2 | Active not recruiting | Chipscreen Biosciences, Ltd. | 42 | 2024-08-13 | 2026-10-23 |
| Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. Chiauranib - Small Cell Lung Cancer, Advanced Solid Malignant Tumor | Phase 1 / Phase 2 | Unknown | Chipscreen Biosciences, Ltd. | 36 | 2022-08-26 | 2024-07-16 |
| Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) Chiauranib - Soft Tissue Sarcoma | Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 40 | 2022-08-25 | 2025-04-03 |
| Mass Balance Study of [14C]Chiauranib Chiauranib - Small Cell Lung Cancer | Not applicable | Completed | Chipscreen Biosciences, Ltd. | 6 | 2022-07-20 | 2024-07-15 |
| Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers Chiauranib - Healthy Volunteers | Phase 1 | Completed | Chipscreen Biosciences, Ltd. | 16 | 2022-06-02 | 2023-02-09 |
| Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer chiauranib, Placebo, Paclitaxel - Ovarian Cancer, Relapsed or Refractory | Phase 3 | Recruiting | Chipscreen Biosciences, Ltd. | 454 | 2021-12-20 | 2024-10-18 |
| A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC Chiauranib, capecitabine - Triple-negative Breast Cancer | Phase 2 | Terminated | Chipscreen Biosciences, Ltd. | 9 | 2021-11-05 | 2025-03-24 |
| Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer Chiauranib, Placebo - Small Cell Lung Cancer | Phase 3 | Completed | Chipscreen Biosciences, Ltd. | 184 | 2021-03-05 | 2024-12-09 |
| Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma Chiauranib, Chidamide - Non-hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 9 | 2019-07-11 | 2022-03-09 |
| Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer chiauranib, etoposide, paclitaxel - Ovarian Cancer | Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 47 | 2019-07-01 | 2021-03-19 |
| Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma Chiauranib - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 27 | 2018-04-28 | 2021-06-18 |
| Phase Ib Study of Chiauranib in Patients With Ovarian Cancer Chiauranib - Ovarian Cancer | Phase 1 / Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 25 | 2017-12-15 | 2020-01-18 |
| Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer Chiauranib - Small Cell Lung Cancer | Phase 1 | Completed | Chipscreen Biosciences, Ltd. | 48 | 2017-11-09 | 2023-08-30 |
| Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma Chiauranib - Non-Hodgkin's Lymphoma | Phase 1 | Terminated | Chipscreen Biosciences, Ltd. | 5 | 2017-05-09 | 2019-07-24 |
| Phase I Study of Chiauranib in Patients With Advanced Solid Tumors Chiauranib - Solid Tumors | Phase 1 | Completed | Chipscreen Biosciences, Ltd. | 18 | 2014-02-01 | 2016-06-17 |
Recurrence (4) · Small Cell Lung Carcinoma (4) · Ovarian Neoplasms (3) · Lymphoma, Non-Hodgkin (2) · Carcinoma, Hepatocellular (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Sarcoma (1) · Triple Negative Breast Neoplasms (1)
Chipscreen Biosciences, Ltd. (16)
China (15) · United States (1)
Xiaohua Wu (2) · Yuankai Shi (2) · Cabilia Pichardo, MD (1) · Jianan Huang (1) · LiYan Miao (1) · Xianjun Yu (1) · Xing Zhang, MD (1)